Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

NCT06884618 ·Status: RECRUITING ·Phase: PHASE1

Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours

NCT01112397 ·Status: TERMINATED ·Phase: PHASE1

A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors

NCT02760797 ·Status: COMPLETED ·Phase: PHASE1

Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors

NCT06362590 ·Status: AVAILABLE

A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies.

NCT02578316 ·Status: COMPLETED ·Phase: PHASE1

A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer

NCT06184035 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)

NCT01433991 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors

NCT00165802 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

NCT05907980 ·Status: RECRUITING ·Phase: PHASE1

A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer

NCT06163391 ·Status: RECRUITING ·Phase: PHASE1

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00734890 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686 ·Status: RECRUITING ·Phase: PHASE1

Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors

NCT05262530 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study of NEO-201 in Solid Tumors Expansion Cohorts

NCT03476681 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

NCT06872489 ·Status: AVAILABLE

A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors

NCT04397276 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid Tumors

NCT00794781 ·Status: COMPLETED ·Phase: PHASE1

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

NCT00557856 ·Status: COMPLETED ·Phase: PHASE1

A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.

NCT00773526 ·Status: COMPLETED ·Phase: PHASE1

Study of E7046 in Subjects With Selected Advanced Malignancies

NCT02540291 ·Status: TERMINATED ·Phase: PHASE1

Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies

NCT00629200 ·Status: COMPLETED ·Phase: PHASE1

A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors

NCT05631327 ·Status: TERMINATED ·Phase: PHASE1

A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations

NCT05769075 ·Status: RECRUITING ·Phase: PHASE1

A Trial of PDL192 in Subjects With Advanced Solid Tumors

NCT00738764 ·Status: COMPLETED ·Phase: PHASE1

SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

NCT00121290 ·Status: COMPLETED ·Phase: PHASE1